People who received weekly injections of semaglutide -- the active agent in the diabetes drug Ozempic and the weight-loss medication Wegovy -- had a nearly 14% decrease in their body weight after 68 weeks,

Osteoarthritis, the most common form of arthritis, is primarily caused by wear and tear on the protective layer of cartilage on the ends of our bones.

New research shows that weight loss drugs semaglutide, known as Ozempic and Wegovy, not only aid in weight loss but also reduce knee osteoarthritis pain. In a clinical trial, patients who used the drug along with diet and exercise experienced significant weight loss and pain relief.

A new study reported in the New England Journal of Medicine found that GLP-1 drugs such as Ozempic and Wegovy which have semaglutide can help obese people manage knee arthritis. Added weight can place more stress on the knee,